Recombinant Orientia tsutsugamushi tRNA pseudouridine synthase A (truA)

Shipped with Ice Packs
In Stock

Description

Overview of Recombinant Orientia tsutsugamushi tRNA Pseudouridine Synthase A (TruA)

Recombinant Orientia tsutsugamushi tRNA pseudouridine synthase A (TruA) is an engineered enzyme derived from the obligate intracellular bacterium O. tsutsugamushi, the causative agent of scrub typhus. TruA belongs to the pseudouridine synthase family, which catalyzes the isomerization of uridine to pseudouridine (Ψ) in tRNA molecules, a critical post-transcriptional modification for translational accuracy and stability . Unlike TruB (which modifies position 55 in tRNA), TruA targets uridines at positions 38–40 in the anticodon stem-loop (ASL), a region essential for codon-anticodon interactions .

Recombinant Production

Recombinant TruA is typically expressed in E. coli systems using plasmids such as pET47b or pRSET-B, which incorporate affinity tags (e.g., 6× His-tag) for purification . The enzyme is often isolated from inclusion bodies via urea denaturation and refolded through dialysis .

ParameterDetails
Host SystemE. coli BL21(DE3)
VectorpET47b, pRSET-B
Tag6× His-tag at N-terminus
Purification MethodNi-NTA affinity chromatography, urea solubilization, and dialysis
Molecular Weight~36–40 kDa (predicted based on homologous sequences)

Diagnostic and Therapeutic Potential

  • Antigenic Studies: While TruA itself is not a diagnostic target, recombinant proteins like the 56-kDa TSA antigen of O. tsutsugamushi have been validated for serodiagnosis (e.g., ELISA) . TruA’s conservation suggests potential utility in bacterial viability assays or as a target for novel antibiotics .

  • Functional Studies: Recombinant TruA enables mechanistic studies of tRNA modification in O. tsutsugamushi, which lacks robust genetic tools .

Limitations

  • Low Solubility: Recombinant TruA often forms inclusion bodies, necessitating denaturation-refolding protocols that may affect activity .

  • Sequence Variability: Genetic diversity in O. tsutsugamushi strains (e.g., Karp, Gilliam) could necessitate strain-specific TruA variants .

Comparative Analysis with Homologs

FeatureO. tsutsugamushi TruAE. coli TruA
Target SitestRNA positions 38–40tRNA positions 38–40
Genomic StabilityCore gene amid high genomic plasticity Stable, non-redundant genome
Recombinant YieldLow (requires optimization) High
Structural DataLimited (homology models only)Crystal structures available

Future Directions

  • Structural Studies: Cryo-EM or crystallography of recombinant TruA could elucidate binding dynamics in O. tsutsugamushi.

  • Functional Knockdown: RNA interference or CRISPR-based approaches may clarify TruA’s role in bacterial fitness .

  • Diagnostic Integration: Exploration of TruA-derived peptides for scrub typhus biomarker panels .

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but if you have specific requirements, please note them when ordering, and we will accommodate your request.
Lead Time
Delivery times vary by purchase method and location. Please consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance, as additional charges apply.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form is stable for 6 months at -20°C/-80°C, while the lyophilized form is stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
truA; OTT_0928; tRNA pseudouridine synthase A; EC 5.4.99.12; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA-uridine isomerase I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-283
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Orientia tsutsugamushi (strain Ikeda) (Rickettsia tsutsugamushi)
Target Names
truA
Target Protein Sequence
MLRYKAIVEY DGTNFVGWQR QQNGLSIQQL LEDKISTFTK QTVNLIAAGR TDAGVHALGQ VVHFDLISPN NSKDLACINK ETDNKEVSKQ NNTTTTIDSL KMLPCRYNAY KLMSAVNYLL KPHRIILTSC EITTLQFHAR FSAKARHYKY RIINRAVPSV IEQNRTWWIK TPLNVIDMID ASQHLIGKHD FTSFRSSACQ AKSPLKTLTK IEVDTTNYPE IQIYFSAPSF LHHMVRNIVG TLVYIGLCKI SPAAIKTILF AKNRAMAGPT APSSGLYFVK VDY
Uniprot No.

Target Background

Function
Forms pseudouridine at positions 38, 39, and 40 in the anticodon stem and loop of transfer RNAs.
Database Links

KEGG: ott:OTT_0928

Protein Families
TRNA pseudouridine synthase TruA family

Q&A

What is the primary function of tRNA pseudouridine synthase A (truA) in Orientia tsutsugamushi?

tRNA pseudouridine synthase A (truA) in O. tsutsugamushi catalyzes the conversion of uridine to pseudouridine at positions 38, 39, and 40 in the anticodon stem-loop of tRNA molecules. This post-transcriptional modification is crucial for proper tRNA folding, stability, and accurate codon recognition during protein synthesis. In bacterial pathogens like O. tsutsugamushi, truA contributes to translational fidelity, which can impact virulence and adaptation to host environments. The enzyme's function is particularly important during bacterial replication within host cells, where efficient protein synthesis is essential for pathogen survival and propagation.

What experimental methods are most effective for isolating recombinant O. tsutsugamushi truA protein?

For efficient isolation of recombinant O. tsutsugamushi truA protein, a true experimental design with appropriate controls is essential . The most effective approach involves:

  • Gene cloning: Amplify the truA gene from O. tsutsugamushi genomic DNA using PCR with high-fidelity polymerase.

  • Expression vector construction: Clone the gene into a bacterial expression vector (pET system) with an N-terminal His-tag.

  • Expression optimization: Test multiple expression conditions (temperature, IPTG concentration, duration) in E. coli BL21(DE3).

  • Protein purification: Use nickel affinity chromatography followed by size-exclusion chromatography.

  • Validation: Confirm protein identity and purity through SDS-PAGE, Western blotting, and mass spectrometry.

Researchers should implement task replication strategies to ensure experimental reliability, similar to approaches used in distributed computational systems where task redundancy improves outcome reliability .

How do genetic variations in O. tsutsugamushi truA correlate with virulence and host adaptation?

Genetic variations in O. tsutsugamushi truA may significantly impact virulence and host adaptation through several mechanisms. The heterogeneity of O. tsutsugamushi genotypes observed within individual mites (17.9% containing mixed infections) suggests ongoing genetic exchange and adaptation . To investigate correlations between truA variations and virulence:

  • Sequence truA genes from multiple clinical and environmental isolates

  • Classify variants based on:

    • Amino acid substitutions in catalytic domains

    • Modifications in regulatory regions

    • Presence of strain-specific insertions/deletions

Then analyze these variations against virulence metrics using:

Analysis ApproachData RequiredExpected Outcomes
Phylogenetic mappingtruA sequences from multiple strainsEvolutionary relationships between variants
Structure-function analysisCrystal structures of variant proteinsImpact of mutations on enzyme activity
Infection modelsIn vitro cell infection assaysCorrelation between variants and infection efficiency
TranscriptomicsRNA-seq data from infected tissuesExpression patterns across infection stages

This approach requires true experimental design with randomized samples and appropriate controls to establish causative relationships rather than mere associations .

What methodological challenges arise when investigating truA-mediated tRNA modifications in O. tsutsugamushi, and how can they be addressed?

Investigating truA-mediated tRNA modifications in O. tsutsugamushi presents several methodological challenges:

  • Organism cultivation: O. tsutsugamushi is an obligate intracellular pathogen requiring host cells for propagation, complicating isolation of bacterial RNA.

    • Solution: Develop selective lysis protocols to separate bacterial and host cell contents, followed by rapid RNA stabilization.

  • Low RNA yields: Limited bacterial mass from infected cell cultures results in minimal RNA extraction.

    • Solution: Implement carrier RNA strategies and specialized small-sample RNA extraction protocols.

  • Pseudouridine detection specificity: Traditional methods may not distinguish truA-specific modifications from other pseudouridylation events.

    • Solution: Employ CMC (N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide) treatment followed by RNA-seq to map pseudouridine sites with single-nucleotide resolution.

  • Genotype heterogeneity: The presence of multiple O. tsutsugamushi genotypes within individual vectors complicates genotype-phenotype correlations .

    • Solution: Implement single-cell approaches or develop strain-specific markers for accurate genotyping before modification analysis.

Researchers should incorporate redundancy in experimental design, similar to task replication approaches used in computational systems, to ensure reliable results despite these technical challenges .

What true experimental design elements are crucial when studying recombinant O. tsutsugamushi truA protein function?

When studying recombinant O. tsutsugamushi truA protein function, implementing a true experimental design is essential for establishing valid cause-effect relationships . Critical design elements include:

  • Random assignment: When testing truA activity under various conditions, randomly assign samples to treatment groups to eliminate selection bias . For instance, when assessing the impact of different cations on truA activity, samples should be randomly allocated to each experimental condition.

  • Control groups: Establish proper negative controls (heat-inactivated truA) and positive controls (well-characterized pseudouridine synthase from E. coli) to validate experimental outcomes .

  • Variable manipulation: Systematically manipulate independent variables (temperature, pH, substrate concentration) while controlling confounding factors. This approach helps identify optimal conditions for truA activity and stability.

  • Replication strategy: Implement a task replication approach similar to computational systems by performing experimental repeats across different days and by different researchers to ensure reliability .

  • Blinding procedures: When analyzing enzyme activity data, ensure researchers are blinded to sample identity to prevent unconscious bias in data interpretation.

Experimental VariableControl StrategyMeasurement Approach
TemperatureWater bath with ±0.1°C precisionActivity assays at 5°C intervals (25-45°C)
pHBuffered systems with overlapping rangesActivity measurement in 0.5 pH unit increments
tRNA substratesSize-matched tRNAs lacking target sitesPseudouridine quantification by LC-MS/MS
Divalent cationsEDTA chelation followed by defined supplementationActivity comparison across physiological concentrations

How can researchers effectively study the impact of O. tsutsugamushi strain heterogeneity on truA function?

To effectively study the impact of O. tsutsugamushi strain heterogeneity on truA function, researchers should implement a comprehensive approach that accounts for the complex nature of multi-strain infections observed in field-collected vectors :

  • Strain isolation and characterization:

    • Culture and isolate individual strains from field samples

    • Sequence the 56-kDa TSA gene for strain typing

    • Perform whole-genome sequencing to identify truA gene variants

  • Recombinant protein expression:

    • Clone truA genes from multiple strains

    • Express and purify proteins under identical conditions

    • Validate protein folding through circular dichroism spectroscopy

  • Comparative enzyme kinetics:

    • Measure enzyme activity using identical substrate concentrations

    • Determine Km and Vmax parameters for each variant

    • Analyze temperature and pH optima across variants

  • Co-infection models:

    • Create defined mixed populations of O. tsutsugamushi strains

    • Measure competitive fitness and truA expression levels

    • Track changes in population composition over multiple passages

  • Anomaly detection:

    • Implement statistical methods similar to the RRCF algorithm to identify outlier strains

    • Filter experimental data to exclude anomalous results

    • Apply appropriate statistical corrections for multiple testing

This approach requires a true experimental design with proper randomization and controls to establish cause-effect relationships between strain variation and truA function .

What statistical approaches are most appropriate for analyzing truA activity data across different O. tsutsugamushi strains?

When analyzing truA activity data across different O. tsutsugamushi strains, researchers should employ statistical approaches that account for the complex heterogeneity observed in these bacteria . The following methodological framework is recommended:

  • Preliminary data assessment:

    • Test for normality using Shapiro-Wilk test

    • Check for homoscedasticity using Levene's test

    • Identify outliers using methods similar to the RRCF algorithm used in computational systems

  • Comparative analysis across strains:

    • For normally distributed data: One-way ANOVA followed by Tukey's post-hoc test

    • For non-normally distributed data: Kruskal-Wallis test followed by Dunn's test

    • For repeated measures: Mixed-effects models to account for batch effects

  • Correlation analysis for structure-function relationships:

    • Multiple regression models relating amino acid substitutions to enzyme kinetics

    • Principal component analysis to identify patterns in multidimensional datasets

    • Hierarchical clustering to group functionally similar truA variants

  • Visualization techniques:

    • Forest plots for comparing effect sizes across strains

    • Heat maps for visualizing activity across conditions

    • Interaction plots for identifying strain-specific responses to environmental factors

  • Validation approaches:

    • Cross-validation using random subsetting of data

    • Bootstrap resampling to establish confidence intervals

    • Sensitivity analysis by varying statistical parameters

This statistical framework adheres to true experimental design principles by ensuring proper control of variables and randomization, essential for establishing valid cause-effect relationships .

How should researchers address contradictory findings in truA functional studies from different O. tsutsugamushi isolates?

When confronting contradictory findings in truA functional studies from different O. tsutsugamushi isolates, researchers should implement a systematic approach to resolve discrepancies:

  • Source verification and standardization:

    • Authenticate strain identities through multi-locus sequence typing

    • Standardize growth conditions and protein purification protocols

    • Verify recombinant protein integrity through mass spectrometry and CD spectroscopy

  • Methodological harmonization:

    • Develop and distribute reference materials (standardized substrates, buffers)

    • Establish consensus protocols for activity assays

    • Implement interlaboratory validation studies

  • Contextual analysis of contradictions:

    • Create a comprehensive data table documenting experimental conditions across studies

    • Identify potential confounding variables (host cell type, growth phase, extraction method)

    • Apply meta-analysis techniques to quantify the impact of methodological differences

  • Heterogeneity assessment:

    • Investigate whether contradictions arise from natural strain variations

    • Determine if mixed infections in original isolates contribute to variability

    • Sequence truA genes and regulatory regions from contradictory isolates

  • Experimental resolution strategy:

Contradiction TypeInvestigation ApproachResolution Method
Activity level differencesSide-by-side testing with standardized substratesIdentify strain-specific or methodology-related factors
Substrate specificity variationsCross-laboratory exchange of strains and protocolsDetermine if differences are reproducible across labs
Temperature/pH optima discrepanciesSystematic parameter scanning with identical protocolsEstablish strain-specific response curves
Inhibitor sensitivity differencesDose-response curves with authenticated compoundsIdentify strain-specific resistance mechanisms

This approach follows true experimental design principles by implementing proper controls and randomization , while also accounting for the potential impact of mixed strain infections observed in natural settings .

What novel experimental approaches could advance our understanding of truA's role in O. tsutsugamushi pathogenesis?

To advance our understanding of truA's role in O. tsutsugamushi pathogenesis, researchers should explore these novel experimental approaches:

  • CRISPR interference (CRISPRi) systems:

    • Develop inducible knockdown systems for truA in O. tsutsugamushi

    • Quantify changes in pseudouridylation patterns across the transcriptome

    • Measure impacts on bacterial fitness during intracellular growth

  • Single-cell RNA sequencing of infected hosts:

    • Profile host-pathogen interactions at single-cell resolution

    • Correlate truA expression levels with host cell responses

    • Identify cell type-specific dependencies on truA function

  • Structural biology approaches:

    • Determine high-resolution crystal structures of O. tsutsugamushi truA

    • Employ molecular dynamics simulations to predict strain-specific functional differences

    • Design structure-based inhibitors as research tools

  • Translational fidelity assays:

    • Develop reporter systems to measure mistranslation rates

    • Compare translation accuracy between wild-type and truA-deficient strains

    • Identify specific codons affected by altered pseudouridylation

  • Mouse models with strain-specific infections:

    • Create humanized mouse models for O. tsutsugamushi infection

    • Compare virulence between strains with variant truA alleles

    • Evaluate tissue tropism in relation to truA expression patterns

This research agenda requires true experimental design principles, including proper randomization and control groups , while accounting for the heterogeneity of O. tsutsugamushi strains observed in natural settings . Researchers should implement task replication strategies to ensure robust and reproducible results .

How might truA inhibitors be developed as research tools for investigating O. tsutsugamushi biology?

The development of truA inhibitors as research tools for investigating O. tsutsugamushi biology represents a promising approach for understanding this enzyme's role in bacterial pathogenesis. A comprehensive methodology involves:

  • Target-based inhibitor design:

    • In silico screening against predicted truA active site structures

    • Fragment-based drug discovery using NMR or X-ray crystallography

    • Rational design based on transition state analogues

  • Phenotypic screening approaches:

    • Development of high-throughput pseudouridylation assays

    • Screening of diverse chemical libraries against recombinant truA

    • Counter-screening against human pseudouridine synthases for selectivity

  • Validation and optimization strategy:

Development StageMethodological ApproachSuccess Criteria
Initial screeningEnzyme inhibition assays with recombinant truAIC₅₀ < 10 μM
Selectivity assessmentTesting against related bacterial and human enzymes>10-fold selectivity
Cell penetrationTesting in infected cell modelsMaintenance of activity in cellular context
Structure-activity relationshipSystematic modification of lead compoundsImproved potency while maintaining selectivity
Probe developmentAddition of reporter groups (fluorescent, clickable)Retention of inhibitory activity
  • Application as research tools:

    • Time-resolved inhibition to determine truA's role at different infection stages

    • Combination with transcriptomics to identify truA-dependent gene expression

    • Spatial inhibition to study tissue-specific requirements for truA activity

  • Potential challenges and solutions:

    • Challenge: Poor cellular penetration
      Solution: Implement targeted delivery systems or prodrug approaches

    • Challenge: Toxicity to host cells
      Solution: Design selective inhibitors based on structural differences between bacterial and human enzymes

    • Challenge: Strain heterogeneity affecting inhibitor efficacy
      Solution: Test against truA variants from diverse O. tsutsugamushi strains

This approach adheres to true experimental design principles by including appropriate controls and randomization of test conditions , while accounting for the heterogeneity observed in O. tsutsugamushi populations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.